Sarepta Therapeutics (SRPT) Stock Price, Quote, News & History | Benzinga

Sarepta Therapeutics Inc (SRPT) Stock Price, Quote, News & History

SRPTNASDAQ

Trade with Public

Trade with Public

$20.30

-0.12-0.59%

At close: Apr 24, 5:00 PM EST

$20.20

-0.10-0.49%

After Hours: 7:44 PM EST

Earnings: Q1 2026 Earnings in 11 days from now on Wed May 6th, after the market close

OverviewNews Earnings Options Guidance Analyst Ratings Insider Trades Short Interest Government Trades Stock Report

Key Statistics

Open

$20.65

Close

$20.30

Volume / Avg.

2.08M / 2.92M

Day Range

$19.93 - $20.68

52 Wk Range

10.42 - 64.80

Market Cap

$2.12B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

47

Short Interest

28.46%

Days to Cover

6.26

Recent Sarepta Therapeutics Inc News

Urban-gro, DraftKings, Sarepta Therapeutics, Destiny Tech100 And AMD: Why These 5 Stocks Are On Investors' Radars Today

U.S. stocks closed higher on Wednesday, with the Dow Jones Industrial Average up 0.66% at 46,429.49, the S&P 500 gaining 0.5% to 6,591.90.

Shivdeep Dhaliwal

Why Is Sarepta Therapeutics Stock Exploding Today?

Sarepta stock jumps after siRNA data show protein reduction, while analysts remain split on outlook and valuation.

Vandana Singh

Sarepta To Request FDA For Traditional Approvals For Duchenne Drugs

Sarepta stock slips after FDA update and mixed trial results, as investors weigh approval hopes against weak data signals.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-205.48M

Investing Cash Flow (TTM)

69.64M

Financing Cash Flow (TTM)

-168.34M

Free Cash Flow (TTM)

-315.33M

Capital Expenditure (TTM)

-109.85M

Net Change in Cash (TTM)

-304.18M

Analyst Trends and Forecast

1

Dec 25

1

2

Jan

1

Feb

2

4

Mar

1

Apr

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

2.5

Sell

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$2.23B

PE Ratio (TTM)

-

PE Ratio (FWD)

5.39

PEG Ratio (TTM)

-

PS Ratio (TTM)

0.93

PB Ratio (TTM)

1.88

Earnings Yield % (TTM)

-34.94%

Earnings Yield % (FWD)

18.55%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$10.86

Company Debt

Total Debt

$828.97M

LT Debt

$828.97M

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-$162.59M

Total Cash

$801.28M

Debt to Equity

0.91

Issuance of Debt (TTM)

-$162.59M

Repayment of Debt (TTM)

-$162.59M

Key Statistics

Open

$20.65

Close

$20.30

Volume / Avg.

2.08M / 2.92M

Day Range

$19.93 - $20.68

52 Wk Range

10.42 - 64.80

Market Cap

$2.12B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

47

Short Interest

28.46%

Days to Cover

6.26

About

Sector

Health Care

Industry

Biotechnology

Sarepta Therapeutics Inc is a commercial-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, gene therapies, and other genetic medicines for rare diseases, particularly neuromuscular disorders. The comp...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Sarepta Therapeutics (SRPT) stock?

A

You can purchase shares of Sarepta Therapeutics (NASDAQ:SRPT) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Sarepta Therapeutics (SRPT) competitors?

A

There are no as such competitors for Sarepta Therapeutics.

Q

What is the forecast, or price target, for Sarepta Therapeutics (SRPT) stock?

A

Sarepta Therapeutics has a consensus price target of $26.74.

Q

What is the current price for Sarepta Therapeutics (SRPT)?

A

The stock price for Sarepta Therapeutics (NASDAQ: SRPT) is $20.2 last updated April 24, 2026 at 7:44 PM EDT.

Q

Does Sarepta Therapeutics (SRPT) pay a dividend?

A

There are no upcoming dividends for Sarepta Therapeutics.

Q

When is Sarepta Therapeutics (NASDAQ:SRPT) reporting earnings?

A

Sarepta Therapeutics does not have any upcoming earnings scheduled.

Q

Is Sarepta Therapeutics (SRPT) going to split?

A

There is no upcoming split for Sarepta Therapeutics.

Q

What sector and industry does Sarepta Therapeutics (SRPT) operate in?

A

Sarepta Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.